Global Collaboration Iaso Ventures engages internationally through partnerships and investment activity, including co-investments with EQT Dementia Fund and activity across the brain health sector. This suggests opportunities for cross-border syndication and joint ventures with specialty biotech and CNS-focused funds.

Early-Stage Focus With a lean team and emphasis on supporting early-stage ventures via the Iaso Venture Studio and NeuroImpact initiatives, there is potential for deal flow from seed to Series A opportunities, as well as accelerator-like programs to source and de-risk investments.

Brain Health Niche A clear focus on brain health and CNS diseases presents a targeted market for strategic partners in biotech, pharmaceuticals, and clinical research, enabling tailored outreach for startups developing RNA therapies, brain shuttle technologies, and precision medicine tools.

Strategic Partnerships Existing partnerships with industry players and foundations (for example Epilepsy Foundation collaboration) indicate receptivity to co-investment and fund initiatives, creating avenues to pitch joint funds, grant-aligned programs, and co-branded investment rounds.

Operational Expertise The founder-operator model and venture studio background provide a value proposition for startups seeking hands-on support in go-to-market, regulatory strategy, and operational scaling, offering sales motions centered on strategic guidance and execution support.